^
BRCA2 mutation
Ovarian Cancer
BGB-290
Sensitive
:
A1
BeiGene Press Release - 1d
BRCA1 mutation
Ovarian Cancer
BGB-290
Sensitive
:
A1
BeiGene Press Release - 1d
No biomarker
Ovarian Cancer
Krabeva (bevacizumab biosimilar)
Sensitive
:
A1
Biocon Press Release - 1wk
No biomarker
Ovarian Cancer
olaparib + bevacizumab
Sensitive
:
A2
NICE - 1wk
HRD
Ovarian Cancer
olaparib + bevacizumab
Sensitive
:
A1
NICE - 1wk
BRCA2 mutation
Ovarian Cancer
PARP inhibitor
Sensitive
:
B
JCO Glob Oncol - 3wk
BRCA1 mutation
Ovarian Cancer
PARP inhibitor
Sensitive
:
B
JCO Glob Oncol - 3wk
BRCA1 mutation
Ovarian Cancer
olaparib
Sensitive
:
A1
Lancet Oncol - 3wk
BRCA2 mutation
Ovarian Cancer
olaparib
Sensitive
:
A1
Lancet Oncol - 3wk
CCNE1 overexpression
Ovarian Cancer
AZD1775
Sensitive
:
C3
Clin Cancer Res - 3wk
No biomarker
Ovarian Cancer
niraparib
Sensitive
:
A1
BRCA1 mutation
Ovarian Cancer
rucaparib
Sensitive
:
A1
BRCA2 mutation
Ovarian Cancer
rucaparib
Sensitive
:
A1
BRCA1 mutation
Ovarian Cancer
olaparib + bevacizumab
Sensitive
:
A1
BRCA2 mutation
Ovarian Cancer
olaparib + bevacizumab
Sensitive
:
A1
No biomarker
Ovarian Cancer
Aybintio (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Ovarian Cancer
Mvasi (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Ovarian Cancer
pegylated liposomal doxorubicin
Sensitive
:
A1
No biomarker
Ovarian Cancer
topotecan
Sensitive
:
A1
No biomarker
Ovarian Cancer
carboplatin + micellar paclitaxel
Sensitive
:
A1
No biomarker
Ovarian Cancer
bevacizumab
Sensitive
:
A1
BRCA1 mutation
Ovarian Cancer
niraparib
Sensitive
:
A1
BRCA2 mutation
Ovarian Cancer
niraparib
Sensitive
:
A1
No biomarker
Ovarian Cancer
Aybintio (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Ovarian Cancer
trabectedin
Sensitive
:
A1
HRD
Ovarian Cancer
niraparib
Sensitive
:
A1
No biomarker
Ovarian Cancer
olaparib
Sensitive
:
A1
No biomarker
Ovarian Cancer
rucaparib
Sensitive
:
A1
No biomarker
Ovarian Cancer
Zirabev (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Ovarian Cancer
Bevax (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Ovarian Cancer
docetaxel
Sensitive
:
A2
No biomarker
Ovarian Cancer
carboplatin + docetaxel
Sensitive
:
A2
No biomarker
Ovarian Cancer
ifosfamide
Sensitive
:
A2
No biomarker
Ovarian Cancer
5-fluorouracil
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our